Past Attendees
- Syngenta
- AstraZeneca
- Kymab
- Bayer Intellectual Property
- Merck Sharp & Dohme
- Eli Lilly
- Gilead
- Tigenix
- Monsanto
- Lundbeck
- Novartis
- NBE Therapeutics
- Gilead
- Sotio
- F-Star
- Teva
“The IP Life Science Summit 2016 was a rewarding experience due to the competent and experienced faculty addressing current complex issues that are of interest to those who are involved with intellectual Property.” – Past attendee
“The hottest topics were covered by high level speakers and the networking opportunities were great” – Nicolas Ruiz, Esteve
“Very interesting, size of group was excellent” – Dr Margrit Hillmann, Bayer HealthCare
“Excellent content, interesting subjects” – Simon Bradbury, Appleyard Lees
“Very interactive and great examples of case law” – Sakura Holloway, Benitec Biopharma
“I really enjoyed the conference, it had a good choice of presentations” – Lindsey Kent, Eli Lilly
“Very well organized, all speakers of high quality” – Past attendee
Come and join our expert speakers and attendees from around the world and benefit from two days of unrivalled insight with lively, interactive discussion and ample networking opportunities
A MUST-ATTEND EVENT FOR:
- In-House General Counsel
- Head of IP
- Directors of IP, Patents and Legal Affairs
- VP/SCP of Patents
- IP Counsel
- IP Managers
- Patent Managers
- Head of R&D
- Intellectual Property and Patent
- Life Sciences
- European Patent